<DOC>
	<DOCNO>NCT00132665</DOCNO>
	<brief_summary>The purpose study evaluate whether radiotherapy carboplatin result longer survival radiotherapy alone elderly patient unresectable stage III NSCLC .</brief_summary>
	<brief_title>Trial Evaluate Radiotherapy With Without CBDCA Elderly Patients With Non-Small Cell Lung Cancer ( JCOG0301 )</brief_title>
	<detailed_description>The purpose study evaluate whether radiotherapy carboplatin result longer survival radiotherapy alone elderly patient unresectable stage III NSCLC .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically and/or cytologically proven NSCLC Unresectable disease Stage IIIA except T3N1M0 IIIB disease extend contralateral hilar node , atelectasis entire lung malignant pleural effusion A required radiation field less one half one lung Measurable disease No previous chemotherapy radiotherapy Age &gt; = 71 Unable receive cisplatinbased combination chemotherapy ECOG performance status ( PS ) 02 Adequate bone marrow , lung , hepatic , renal function Written inform consent Active infection , diarrhea , ileus , uncontrolled diabetes , myocardial infarction within three month , severe comorbidity Synchronous cancer metachronous ( within 5 year ) malignancy Interstitial pneumonia active lung fibrosis chest Xray Severe chronic obstructive pulmonary disease , chronic bronchitis , bronchial asthma Pleural pericardial effusion A history severe hypersensitivity Mental disorder Judging inappropriate condition study physician</criteria>
	<gender>All</gender>
	<minimum_age>71 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>elderly patient</keyword>
	<keyword>carboplatin</keyword>
	<keyword>chemoradiotherapy</keyword>
</DOC>